Home›Companies›Cage Bio

Cage Bio, Inc.

Updated Oct 27, 2026·Latest SEC filing Apr 30, 2025·Suggest an edit

About Cage Bio

Cage Bio is a private company based in San Carlos, California. It has reported $28,803,707 raised in three offerings on Form D since July 2019. Its chief executive is Nitin Joshi.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 15, 2024May 2, 2024amended Apr 30, 2025$10,986,633of $15.0M target14$784KOptions, Securities on exerciseRule 506(b)Form D/A ↗1 earlier filing
Oct 18, 2021Oct 28, 2021$8,462,513of $15.0M target4$2.1MEquityRule 506(b)Form D ↗
Jun 28, 2019Jul 18, 2019amended Feb 22, 2021$9,354,561of $9.8M target56$167KEquityRule 506(b)Form D/A ↗1 earlier filing
Total, three offerings$28,803,707

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Cage Bio's Form D filed Apr 30, 2025.

NJ
Nitin Joshi
CEO and director
JK
Jeff Keyser
Director

Earlier filings also listed Ravi Srinivasan (director, last listed Oct 2021).

Sources

  1. SECCage Bio, Inc. Form D, filed May 2, 2024
  2. SECCage Bio, Inc. Form D, filed Jul 18, 2019
  3. SECCage Bio, Inc. filing history